D-0304-2020 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

Recall Details

Product Type
Drugs
Report Date
November 13, 2019
Initiation Date
November 1, 2019
Termination Date
March 4, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
28,254 bottles

Product Description

Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02

Reason for Recall

Presence of Foreign substance: identified as a dead ant.

Distribution Pattern

Product was distributed to major distributors/wholesalers throughout the United States.

Code Information

Lot #: F802436, F802437, F802438, F802442, Exp 11/20